MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Bradykinesia"

  • 2023 International Congress

    Relationship between bradykinesia and cognitive functions in patients with essential tremor

    G. Paparella, L. Angelini, R. Margiotta, A. Cannavacciuolo, D. Costa, D. Birreci, M. de Riggi, M. Passaretti, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)

    Objective: To investigate the association between bradykinesia, i.e., movement slowness, as objectively assessed with kinematic analysis, and cognitive functions in ET. Background: Bradykinesia in essential…
  • 2023 International Congress

    Axial impairment and bradykinesia are related to increased CSF sTREM2, a neuroinflammation biomarker, in Parkinson’s disease

    A. Brück, R. Ajalin, H. Al-Abdulrasul, H. Zetterberg, K. Blennow, E. Löyttyniemi, J. Rinne (Turku, Finland)

    Objective: To explore the association between Parkinson’s disease (PD) motor symptoms and CSF biomarkers for neuroinflammation and neurodegeneration. Background: Previous in vivo and post mortem…
  • 2023 International Congress

    Risk Factors for Stimulation-Induced Bradykinesia in Dystonia Patients Treated with Deep Brain Stimulation: A Retrospective Analysis.

    F. Lange, B. Karandasch, P. Mahlknecht, J. Kraus, A. Kühn, G. Deuschl, J. Volkmann, M. Reich (Würzburg, Germany)

    Objective: Identification of risk factors for stimulation-induced bradykinesia in GPi-DBS Background: Deep brain stimulation (DBS) is an effective treatment for dystonia, but some patients may…
  • 2023 International Congress

    Enhanced sensitivity to bradykinesia progression using digital health technologies in early Parkinson’s disease

    M. Czech, L. Yang, J. Shen, D. Badley, M. Crouthamel, T. Kangarloo, R. Dorsey, J. Adams, J. Cosman (North Chicago, USA)

    Objective: To evaluate the sensitivity of digital biomarkers of bradykinesia to longitudinal progression relative to MDS-UPDRS sub-scores in early-stage Parkinson’s disease (PD). Background: It is…
  • 2023 International Congress

    Peroperative use of the MDS-UPDRS Motor Section: Agreement between Sitting and Supine position

    A. Smid, N. Kremer, S. Lange, I. Mateus Marçal, K. Tamasi, M. van Dijk, T. van Laar, G. Drost (Groningen, Netherlands)

    Objective: To assess the level of agreement between the MDS-UPDRS-III in sitting and supine position. Background: The clinical effect during stereotactic neurosurgery for Parkinson’s disease…
  • 2023 International Congress

    Asymmetry and side concordance of rest tremor and bradykinesia in patients with essential tremor

    L. Angelini, G. Paparella, D. Costa, D. Birreci, A. Cannavacciuolo, M. Passaretti, D. Colella, A. Berardelli, M. Bologna (Rome, Italy)

    Objective: In the present study, we aimed to investigate the clinical and kinematic features of rest tremor and bradykinesia in patients with essential tremor (ET),…
  • 2023 International Congress

    Make-up for Parkinson’s: a randomized control trial

    M. Darabseh, A. Aburub (Amman, Jordan)

    Objective: To assess the effectiveness of using “applying make-up" as a physiotherapy and occupational therapy intervention to reduce bradykinesia in people with Parkinson’s. Background: People…
  • 2023 International Congress

    Bradykinesia in Patients with Cervical Dystonia: Objective Assessment with Optical Sensor

    Z. Kosutzka, B. Gastanova, P. Matejicka, S. Kajan, P. Valkovic, M. Minar (Bratislava, Slovakia)

    Objective: To objectively quantify selected parameters of bradykinesia investigated by finger tapping in cervical dystonia patients using the Leap Motion Controller (LMC) sensor. Background: Bradykinesia,…
  • 2023 International Congress

    The Short Duration Response and Long Duration Response to L-Dopa are Needed to Restore Vigor-Motivation Coupling in Parkinson Disease

    J. Brissenden, T. Scerbak, R. Albin, T. Lee (Ann Arbor, USA)

    Objective: To assess the relationship between the Short Duration Response (SDR) and Long Duration Response (LDR) to L-Dopa therapy in Parkinson disease (PD) and restoration…
  • 2023 International Congress

    Assessing akinesia domains during multitasking in Parkinson’s disease

    V. Dzialas, M. Banwinkler, M. Höhnig, T. van Eimeren (Cologne, Germany)

    Objective: To explore performance differences in single- versus dual-tasking conditions between healthy controls (HC) and Parkinson's disease (PD) patients. Background: Akinesia, comprising slowness (bradykinesia), reduction…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley